President Trump’s First Week Hammered Public Health
The first week of President Donald Trump’s second term dealt several body blows to public health. Among a flurry of executive ...
Le Lézard21h
Pfizer's BRAFTOVI® Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
Pfizer Inc. today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and mFOLFOX6 (fluorouracil, ...
The New York Times23h
New York Times - Top Stories
Pete Hegseth Is Sworn In as Defense Secretary After Being Confirmed by Slim Margin Mr. Hegseth has vowed to bring his “warrior” ethos to the Pentagon. His confirmation came down to Vice ...